Structure-based virtual screening approach to the discovery of p38 MAP kinase inhibitors

被引：10

作者：

Choi, Hwanho ^{[1
]}

Park, Ho Jeong ^{[2
]}

Shin, Jong Chul ^{[2
]}

Ko, Hyun Sun ^{[2
]}

Lee, Jung Kyun ^{[3
]}

Lee, Soyoung ^{[4
]}

Park, Hwangseo ^{[1
]}

Hong, Sungwoo ^{[4
]}

机构：

[1] Sejong Univ, Dept Biosci & Biotechnol, Seoul 143747, South Korea

[2] Catholic Univ, Coll Med, Seoul St Marys Hosp, Dept Obstet & Gynecol, Seoul 137040, South Korea

[3] Soomshinun Oriental Med Clin, Yongin 448170, Gyeonggi Do, South Korea

[4] Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2012年 / 22卷 / 06期

基金：

新加坡国家研究基金会;

关键词：

Virtual screening; Docking; p38; MAPK; Inhibitor; Anti-inflammatory agents; GENETIC ALGORITHM; PROTEIN-KINASE; POTENT; SOLVATION; DOCKING; IDENTIFICATION; DESIGN;

D O I：

10.1016/j.bmcl.2012.01.104

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

p38 Mitogen-activated protein kinase (MAPK) has been considered to be a promising target for the development of therapeutics for various immunologic diseases. Herein we report an example for a successful application of the virtual screening with protein-ligand docking to identify the novel inhibitors of p38 alpha MAPK. These inhibitors were screened for having desirable physicochemical properties as a drug candidate and compound 1-3 revealed a moderate inhibitory activity with IC50 values ranging from 0.7 to 20 mu M. Therefore, they deserve a consideration for further development by structure-activity relationship (SAR) studies to optimize the inhibitory activities. Structural features relevant to the stabilization of the newly identified inhibitors in the ATP-binding site of p38 MAPK are addressed in detail. (C) 2012 Elsevier Ltd. All rights reserved.

引用

下载

页码：2195 / 2199

页数：5

共 50 条

[11] Structure-based virtual screening of Src kinase inhibitors
Lee, Kyungik
Kim, Jongwoo
Jeong, Ki-Woong
Lee, Ki Won
Lee, Yeonjoo
Song, Ji Yeon
Kim, Maeng Sup
Lee, Gwan Sun
Kim, Yangmee
BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (08) : 3152 - 3161
[12] Potent inhibitors of the map kinase p38
Henry, JR
Rupert, KC
Dodd, JH
Turchi, IJ
Wadsworth, SA
Cavender, DE
Schafer, PH
Siekierka, JJ
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (23) : 3335 - 3340
[13] The development p38 MAP kinase inhibitors
Hynes, John
Wu, H.
Dyckman, A. J.
Lin, S.
Wrobleski, S. T.
Gillooly, K. M.
McIntyre, K. W.
Pitt, S.
Shen, D. R.
Shuster, D. J.
Xia, X.
Zhang, R.
INFLAMMATION RESEARCH, 2007, 56 : S474 - S474
[14] Structure-Based Discovery of Potent Staphylococcus aureus Thymidylate Kinase Inhibitors by Virtual Screening
Qureshi, Bakhtawer
Khalil, Ruqaiya
Saeed, Maria
Nur-e-Alam, Mohammad
Ahmed, Sarfaraz
Ul-Haq, Zaheer
MEDICINAL CHEMISTRY, 2023, 19 (01) : 75 - 90
[15] Discovery of Subtype Selective Janus Kinase (JAK) Inhibitors by Structure-Based Virtual Screening
Bajusz, David
Ferenczy, Gyoergy G.
Keseru, Gyoergy M.
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2016, 56 (01) : 234 - 247
[16] Inhibitors of unactivated p38 MAP kinase
Bullington, James
Argentieri, Dennis
Averill, Kristin
Carter, Demetrius
Cavender, Druie
Fahmy, Bohumila
Fan, Xiaodong
Hall, Daniel
Heintzelman, Geoffrey
Jackson, Paul
Leung, Wai-Ping
Li, Xun
Ling, Ping
Olini, Gilbert
Razler, Thomas
Reuman, Michael
Rupert, Kenneth
Russell, Ronald
Siekierka, John
Wadsworth, Scott
Wolff, Russell
Xiang, Bangping
Zhang, Yue-Mei
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (23) : 6102 - 6106
[17] Discovery and design of novel benzimidazolone as inhibitors of p38 MAP kinase.
Hammach, A
Ralph, M
Corbo, F
Barbosa, A
Liu, PR
Soleymanzadeh, F
Goldberg, D
Sarko, C
Mckibben, B
Moss, N
Hao, MH
White, A
Qian, K
Pargellis, C
Kroe, R
Wildeson, J
Nelson, R
Fadra, T
Capolino, A
Kashem, M
Patnaude, L
Madwed, J
Torcellini, C
Kaplita, P
Farrel, T
Hu, HB
Yazdania, M
Kavanaugh, K
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U947 - U947
[18] Successful screening of large encoded combinatorial libraries leading to the discovery of novel p38 MAP kinase inhibitors
Metzger, A
Diller, DJ
Lin, TH
Henderson, I
Webb, ML
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2006, 9 (05) : 351 - 358
[19] Virtual screening based on pharmacophore model followed by docking simulation studies in search of potential inhibitors for p38 map kinase
Shahlaei, Mohsen
Doosti, Elham
BIOMEDICINE & PHARMACOTHERAPY, 2016, 80 : 352 - 372
[20] Discovery of novel sphingosine kinase 1 inhibitors via structure-based hierarchical virtual screening
Wang, Xiaojian
Sun, Chenbin
Fang, Liang
Yin, Dali
MEDCHEMCOMM, 2015, 6 (03) : 413 - 417

← 1 2 3 4 5 →